Florida Cancer Specialists & Research Institute at ENA 2026

Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website

Florida Cancer Specialists & Research Institute brings 2 presentations to ENA 2026 in Barcelona. Its talks report early clinical results for RAS-targeted drugs. They cover ERAS-0015 in the AURORAS-1 first-in-human trial and QTX3034, an oral G12D-preferring KRAS inhibitor, in KRAS G12D-mutated endometrial cancer.

OrganizationENA 2026 Attendance
Cancer centres & hospitals
Community oncology practice in Florida that runs early-phase cancer trials with Sarah Cannon Research Institute.

Explore the full ENA 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Barcelona. Leave your work email and we’ll be in touch.

Privacy

Download the full ENA 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Florida Cancer Specialists & Research Institute

Tell us what you sell and we’ll find the people at Florida Cancer Specialists & Research Institute most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction